BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 33386567)

  • 1. Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.
    Sterkens A; Lambert J; Bervoets A
    Clin Exp Med; 2021 May; 21(2):215-230. PubMed ID: 33386567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
    Zhou C; Li X; Wang C; Zhang J
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):403-423. PubMed ID: 34403083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
    Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of alopecia areata: An Australian expert consensus statement.
    Cranwell WC; Lai VW; Photiou L; Meah N; Wall D; Rathnayake D; Joseph S; Chitreddy V; Gunatheesan S; Sindhu K; Sharma P; Green J; Eisman S; Yip L; Jones L; Sinclair R
    Australas J Dermatol; 2019 May; 60(2):163-170. PubMed ID: 30411329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Alopecia Areata.
    Afford R; Leung AKC; Lam JM
    Curr Pediatr Rev; 2021; 17(1):45-54. PubMed ID: 32351186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alopecia areata].
    Friedli A; Harms M
    Ther Umsch; 2002 May; 59(5):233-7. PubMed ID: 12090120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Options for Alopecia Areata in Children and Adolescents.
    Westerkam LL; McShane DB; Nieman EL; Morrell DS
    Paediatr Drugs; 2024 May; 26(3):245-257. PubMed ID: 38466519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors.
    Paggioli I; Moss J
    J Autoimmun; 2022 Dec; 133():102926. PubMed ID: 36335798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia areata: An appraisal of new treatment approaches and overview of current therapies.
    Strazzulla LC; Wang EHC; Avila L; Lo Sicco K; Brinster N; Christiano AM; Shapiro J
    J Am Acad Dermatol; 2018 Jan; 78(1):15-24. PubMed ID: 29241773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata.
    Hon KL; Leung AK
    Recent Pat Inflamm Allergy Drug Discov; 2011 May; 5(2):98-107. PubMed ID: 21453266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
    Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
    J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European expert consensus statement on the systemic treatment of alopecia areata.
    Rudnicka L; Arenbergerova M; Grimalt R; Ioannides D; Katoulis AC; Lazaridou E; Olszewska M; Ovcharenko YS; Piraccini BM; Prohic A; Rakowska A; Reygagne P; Richard MA; Soares RO; Starace M; Vañó-Galvan S; Waskiel-Burnat A
    J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):687-694. PubMed ID: 38169088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia areata: pathogenesis and treatment.
    Mitchell AJ; Krull EA
    J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):763-75. PubMed ID: 6210311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata.
    Ito T; Aoshima M; Ito N; Uchiyama I; Sakamoto K; Kawamura T; Yagi H; Hashizume H; Takigawa M
    Arch Dermatol Res; 2009 Jun; 301(5):373-80. PubMed ID: 19301021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alopecia areata: evidence-based treatments.
    Garg S; Messenger AG
    Semin Cutan Med Surg; 2009 Mar; 28(1):15-8. PubMed ID: 19341938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation.
    El Taieb MA; Ibrahim H; Nada EA; Seif Al-Din M
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27791311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
    Yu L; Yu H; Zhang S; Hao Y; Zhang S
    Front Immunol; 2022; 13():904156. PubMed ID: 35795663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Treatment of Alopecia Areata.
    Hordinsky MK
    J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S28-S30. PubMed ID: 33099380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of JAK/STAT pathways and JAK inhibition in alopecia areata.
    Lensing M; Jabbari A
    Front Immunol; 2022; 13():955035. PubMed ID: 36110853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.